Renalytix plc Research and Development Expense (Excluding Acquired in Process Cost)
Renalytix plc (RNLXY) reported Research and Development Expense (Excluding Acquired in Process Cost) of $921.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2024-11-19
- Renalytix plc research and development expense (excluding acquired in process cost) for the quarter ending 2024-09-30 was $921.00K, a 66.95% decline year-over-year.
- Renalytix plc research and development expense (excluding acquired in process cost) for the quarter ending 2024-06-30 was $1.06M, a 67.54% decline year-over-year.
- Renalytix plc research and development expense (excluding acquired in process cost) for the quarter ending 2024-03-31 was $2.22M, a 43.80% decline year-over-year.
- Renalytix plc research and development expense (excluding acquired in process cost) for the quarter ending 2023-12-31 was $3.23M, a 3.04% decline year-over-year.
- Renalytix plc research and development expense (excluding acquired in process cost) for fiscal 2024 was $9.29M, a 35.03% decline from fiscal 2023.
- Renalytix plc research and development expense (excluding acquired in process cost) for fiscal 2023 was $14.30M, a 2.39% decline from fiscal 2022.
- Renalytix plc research and development expense (excluding acquired in process cost) for fiscal 2022 was $14.65M.
| Period end | Research and Development Expense (Excluding Acquired in Process Cost) 3 month | Research and Development Expense (Excluding Acquired in Process Cost) 4 month | Research and Development Expense (Excluding Acquired in Process Cost) 6 month | Research and Development Expense (Excluding Acquired in Process Cost) 9 month | Research and Development Expense (Excluding Acquired in Process Cost) 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $921.00K 10-Q · filed 2024-11-19 | $1.98M derived: sum of 2 quarters · filed 2024-11-19 | $4.20M derived: sum of 3 quarters · filed 2024-11-19 | $7.42M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2024-06-30 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $3.28M derived: sum of 2 quarters · filed 2024-09-30 | $6.50M derived: sum of 3 quarters · filed 2024-09-30 | $9.29M 10-K · filed 2024-09-30 | |
| 2024-03-31 | $2.22M 10-Q · filed 2024-05-15 | $5.44M derived: sum of 2 quarters · filed 2024-05-15 | $8.23M 10-Q · filed 2024-05-15 | $11.50M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-12-31 | $3.23M 10-Q · filed 2024-02-14 | $6.01M 10-Q · filed 2024-02-14 | $9.28M derived: sum of 3 quarters · filed 2024-11-19 | $13.23M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-09-30 | $2.79M 10-Q · filed 2024-11-19 | $6.06M derived: sum of 2 quarters · filed 2024-11-19 | $10.00M derived: sum of 3 quarters · filed 2024-11-19 | $13.33M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2023-06-30 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $7.21M derived: sum of 2 quarters · filed 2024-09-30 | $10.54M derived: sum of 3 quarters · filed 2024-09-30 | $14.30M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $3.94M 10-Q · filed 2024-05-15 | $7.27M derived: sum of 2 quarters · filed 2024-05-15 | $11.03M 10-Q · filed 2024-05-15 | $13.65M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $3.33M 10-Q · filed 2024-02-14 | $7.08M 10-Q · filed 2024-02-14 | $9.71M derived: sum of 3 quarters · filed 2024-02-14 | $13.60M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-09-30 | $3.76M 10-Q · filed 2023-11-14 | $6.39M derived: sum of 2 quarters · filed 2023-11-14 | $10.27M derived: sum of 3 quarters · filed 2023-11-14 | $14.41M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $2.63M derived: 10-K 12 month − 6-K 9 month · filed 2023-09-28 | $6.52M derived: sum of 2 quarters · filed 2023-09-28 | $10.65M derived: sum of 3 quarters · filed 2023-09-28 | $14.65M 10-K · filed 2023-09-28 | |
| 2022-03-31 | $3.89M 6-K · filed 2023-06-09 | $8.02M derived: sum of 2 quarters · filed 2023-06-09 | $12.02M 6-K · filed 2023-06-09 | $14.75M derived: sum of 4 quarters · filed 2023-06-09 | |
| 2021-12-31 | $4.13M 6-K · filed 2023-03-30 | $8.13M 6-K · filed 2023-03-30 | $10.86M derived: sum of 3 quarters · filed 2023-03-30 | $13.96M derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-09-30 | $4.00M 6-K · filed 2022-11-30 | $6.73M derived: sum of 2 quarters · filed 2022-11-30 | $9.83M derived: sum of 3 quarters · filed 2022-11-30 | $12.29M derived: sum of 4 quarters · filed 2022-11-30 | |
| 2021-06-30 | $2.73M derived: 20-F 12 month − 6-K 9 month · filed 2022-10-31 | $5.83M derived: sum of 2 quarters · filed 2022-10-31 | $8.29M derived: sum of 3 quarters · filed 2022-10-31 | $10.04M 20-F · filed 2022-10-31 | |
| 2021-03-31 | $3.10M 6-K · filed 2022-06-30 | $5.57M derived: sum of 2 quarters · filed 2022-06-30 | $7.31M 6-K · filed 2022-06-30 | ||
| 2020-12-31 | $2.46M 6-K/A · filed 2022-04-29 | $4.21M 6-K/A · filed 2022-04-29 | |||
| 2020-06-30 | $4.57M 20-F · filed 2022-10-31 | ||||
| 2019-06-30 | $4.32M 20-F/A · filed 2022-08-01 | ||||
| 2018-06-30 | $193.00K 20-F/A · filed 2020-11-10 |